Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications

Curr Pharm Des. 2020;26(11):1167-1180. doi: 10.2174/1381612826666200206094529.

Abstract

The contemporary drug discovery research shows that most of the drug candidates are highly potent, but showing poor aqueous solubility leads a variety of challenges for formulation scientists to develop a suitable formulation to improve the systemic bioavailability of such drugs. Lipid-based nanocarriers act as a major and most projecting approach overcoming the limitations which affect several physiochemical properties of drug such as the solubility, partition coefficient and bioavailability or absorption. This also fulfills a variety of product requirements and helps to overcome several limitations as decided by symptoms of the disease, various routes of administration of drug, price concern, increasing strength of product, noxious or harmful effect of drug, and dose efficacy. The lipidic nanosystem formulates aqueous drug in lipid base and is also a commercially feasible approach for the formulation of different dosage forms meant for topical or transdermal, oral, ocular, pulmonary, and parenteral delivery. This review provides a brief on lipid-based drug delivery nanocarrier and the mechanisms by which lipids and lipidic excipients improve the oral absorption of drugs with poor aqueous solubility and also provide a viewpoint on the promising applications of lipidic nanoparticulate systems.

Keywords: Drug discovery; aqueous drug; bioavailability; lipid-based nanocarriers; physiochemical properties; poor aqueous solubility..

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Biological Availability
  • Drug Carriers
  • Drug Delivery Systems
  • Lipids
  • Nanoparticles*
  • Pharmaceutical Preparations*
  • Solubility

Substances

  • Drug Carriers
  • Lipids
  • Pharmaceutical Preparations